StockData
Apyx Medical Corp logo

Apyx Medical Corp (APYX) stock

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3018% above fair value
$2.49−0.06 (-2.54%)

Close on Nov 18, 2026Market cap $104.89MP/E –Yield –

Apyx Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Apyx Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$11.05M. For fiscal 2025 it was -$9.12M. The highest annual figure on record is $1.36M in fiscal 2011.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.12M–
FY2024Dec 31, 2024-$18.77M–
FY2023Dec 31, 2023-$5.78M–
FY2022Dec 31, 2022-$21.29M–
FY2021Dec 31, 2021-$11.17M–
FY2020Dec 31, 2020-$16.65M–
FY2019Dec 31, 2019-$19.78M–
FY2018Dec 31, 2018-$21.24M–
FY2017Dec 31, 2017-$4.33M–
FY2016Dec 31, 2016-$3.12M–
FY2015Dec 31, 2015-$6.21M–
FY2014Dec 31, 2014-$1.05M–
FY2013Dec 31, 2013-$3.12M–
FY2012Dec 31, 2012-$588.00K-143.4%
FY2011Dec 31, 2011$1.36M–
FY2010Dec 31, 2010-$727.00K–
FY2009Dec 31, 2009-$2.56M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.56M–
Q1 FY2026Mar 31, 2026-$632.00K–
Q4 FY2025Dec 31, 2025-$2.81M–
Q3 FY2025Sep 30, 2025-$4.06M–
Q2 FY2025Jun 30, 2025-$1.50M–
Q1 FY2025Mar 31, 2025-$757.00K–
Q4 FY2024Dec 31, 2024-$3.18M–
Q3 FY2024Sep 30, 2024-$4.59M-230.4%
Q2 FY2024Jun 30, 2024-$4.62M–
Q1 FY2024Mar 31, 2024-$6.38M–
Q4 FY2023Dec 31, 2023-$2.31M–
Q3 FY2023Sep 30, 2023$3.52M–
Q2 FY2023Jun 30, 2023-$5.01M–
Q1 FY2023Mar 31, 2023-$1.99M–
Q4 FY2022Dec 31, 2022-$4.67M–
Q3 FY2022Sep 30, 2022-$5.55M–
Q2 FY2022Jun 30, 2022-$6.27M–
Q1 FY2022Mar 31, 2022-$4.80M–
Q4 FY2021Dec 31, 2021-$118.00K–
Q3 FY2021Sep 30, 2021-$3.78M–
Q2 FY2021Jun 30, 2021-$5.04M–
Q1 FY2021Mar 31, 2021-$2.24M–
Q4 FY2020Dec 31, 2020-$1.41M–
Q3 FY2020Sep 30, 2020-$2.63M–
Q2 FY2020Jun 30, 2020-$5.12M–
Q1 FY2020Mar 31, 2020-$7.50M–
Q4 FY2019Dec 31, 2019-$3.48M–
Q3 FY2019Sep 30, 2019-$5.11M–
Q2 FY2019Jun 30, 2019-$5.99M–
Q1 FY2019Mar 31, 2019-$5.21M–
Q4 FY2018Dec 31, 2018-$18.21M-3484.0%
Q3 FY2018Sep 30, 2018-$1.03M–
Q2 FY2018Jun 30, 2018-$766.00K–
Q1 FY2018Mar 31, 2018-$1.25M–
Q4 FY2017Dec 31, 2017$538.00K–
Q3 FY2017Sep 30, 2017-$821.00K–
Q2 FY2017Jun 30, 2017-$1.16M–
Q1 FY2017Mar 31, 2017-$2.89M–
Q4 FY2016Dec 31, 2016-$648.00K–
Q3 FY2016Sep 30, 2016-$54.00K–

More Apyx Medical figures

See a number that looks wrong?